Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/61852

TitleMyasthenia gravis: State of the art and new therapeutic strategies
Author(s)Souto, Eliana
Lima, Bernado
Campos, Joana R.
Martins-Gomes, Carlos
Souto, Selma B.
Silva, Amélia M.
KeywordsMyasthenia gravis
Acetylcholine receptors
Neuromuscular junction
Steroids
Immunosuppressant drugs
Rituximab
Eculizumab
Issue date15-Dec-2019
PublisherElsevier
JournalJournal of Neuroimmunology
CitationSouto, Eliana; Lima, Bernado; Campos, Joana R.; Martins-Gomes, Carlos; Souto, Selma B.; Silva, Amélia M., Myasthenia gravis: State of the art and new therapeutic strategies. Journal of Neuroimmunology, 337(577080), 2019
Abstract(s)Myasthenia Gravis (MG) an autoimmune neuromuscular disease is known by the production of autoantibodies against components of the neuromuscular junction mainly to the acetylcholine receptor, which cause the destruction and compromises the synaptic transmission. This disease is characterized by fluctuating and fatigable muscle weakness, becoming more intensive with activity, but with an improvement under resting. There are many therapeutic strategies used to alleviate MG symptoms, either by improving the transmission of the nerve impulse or by ameliorating autoimmune reactions with e.g. steroids, immunosuppressant drugs, or monoclonal antibodies (rituximab and eculizumab). Many breakthroughs in the discovery of new therapeutic targets have been reported, but MG remains to be a chronic disease where the symptoms are kept in the majority of patients. In this review, we discuss the different therapeutic strategies that have been used over the years to alleviate MG symptoms, as well as innovative therapeutic approaches currently under study.
TypeArticle
URIhttp://hdl.handle.net/1822/61852
DOI10.1016/j.jneuroim.2019.577080
ISSN01655728
Publisher versionhttps://www.jni-journal.com
Peer-Reviewedyes
AccessRestricted access (UMinho)
Appears in Collections:CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series

Files in This Item:
File Description SizeFormat 
document_52116_1.pdf
  Restricted access
1,49 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID